STAGE III OVARIAN CANCER AJCC V8
Clinical trials for STAGE III OVARIAN CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III OVARIAN CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III OVARIAN CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heated chemotherapy during surgery: a new hope for ovarian cancer patients?
Disease control Recruiting nowThis study looks at the safety of giving heated chemotherapy directly into the belly during surgery for advanced ovarian, fallopian tube, or peritoneal cancer. About 45 people will receive either chemotherapy before surgery or heated chemotherapy during surgery. The goal is to se…
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:35 UTC
-
Can switching PARP inhibitors outsmart cancer? new trial aims to find out
Disease control Recruiting nowThis study is testing a drug called talazoparib in people with advanced solid tumors that have specific DNA repair gene mutations. The goal is to see if this PARP inhibitor can shrink tumors or slow their growth, even in patients who have already tried a similar drug. About 36 ad…
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:32 UTC
-
New drug combo trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will take …
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
Electric field therapy worn like a vest shows promise against tough cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields to disrupt cancer cell growth, combined with standard drugs (cabozantinib or nab-paclitaxel plus atezolizumab). About 43 adults with advanced solid tumors in the abdomen or chest that have s…
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
Could a simple wash and blood test catch ovarian cancer sooner?
Diagnosis Recruiting nowThis study is testing a new way to detect ovarian cancer earlier by looking at DNA from a uterine wash and proteins in the blood. Researchers will collect samples from 250 women before surgery for a suspected ovarian mass or as a preventive measure for those with BRCA mutations. …
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 26, 2026 05:28 UTC
-
Probiotics may ease chemo side effects in ovarian cancer
Symptom relief Recruiting nowThis study tests whether taking probiotics can improve gut and vaginal health in 161 women with advanced or recurrent ovarian cancer who are receiving platinum chemotherapy. Participants will take either a probiotic or a placebo pill. Researchers will check stool and vaginal samp…
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:36 UTC
-
Wearable tech aims to get cancer patients moving for better health
Symptom relief Recruiting nowThis study tests whether a personalized activity program using a Fitbit can help women with advanced ovarian or endometrial cancer exercise more and improve their quality of life. About 120 participants will either get standard care or the automated program. Researchers will also…
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC
-
Can your social life help you beat Cancer's aftermath?
Knowledge-focused Recruiting nowThis study follows 250 young adults (ages 18-39) recently diagnosed with cancer to see how their social relationships and physical activity change over time and affect their quality of life. Researchers will track hospitalizations, treatment details, exercise habits, and well-bei…
Matched conditions: STAGE III OVARIAN CANCER AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC